Log in to save to my catalogue

A Network Pharmacology-Based Study on Irritable Bowel Syndrome Prevention and Treatment Utilizing Sh...

A Network Pharmacology-Based Study on Irritable Bowel Syndrome Prevention and Treatment Utilizing Sh...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8632384

A Network Pharmacology-Based Study on Irritable Bowel Syndrome Prevention and Treatment Utilizing Shenling Baizhu Powder

About this item

Full title

A Network Pharmacology-Based Study on Irritable Bowel Syndrome Prevention and Treatment Utilizing Shenling Baizhu Powder

Publisher

United States: Hindawi

Journal title

BioMed research international, 2021, Vol.2021 (1), p.4579850-4579850

Language

English

Formats

Publication information

Publisher

United States: Hindawi

More information

Scope and Contents

Contents

Background and Objective. Irritable bowel syndrome (IBS) is a prevalent disorder of the gastrointestinal system with complex pathogenesis. Shenling Baizhu powder (SLBZP) is a Chinese herbal compound with multicomponent and multitarget characteristics. Increasing volumes of evidence demonstrate that it has a notable therapeutic impact on IBS. This s...

Alternative Titles

Full title

A Network Pharmacology-Based Study on Irritable Bowel Syndrome Prevention and Treatment Utilizing Shenling Baizhu Powder

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8632384

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8632384

Other Identifiers

ISSN

2314-6133

E-ISSN

2314-6141

DOI

10.1155/2021/4579850

How to access this item